• A reduction in hemolysis with voxelotor analog, GBT1118, reduced hemoglobinuria and kidney injury biomarkers in transgenic sickle mice. • Improved chronic hemolysis preserved kidney function and histopathologic and ultrastructural changes in transgenic sickle mice.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636314 | PMC |
http://dx.doi.org/10.1182/bloodadvances.2022007809 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!